UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): June 16, 2014
AMERICANN, INC.
---------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 000-54231 27-4336843
------------------------- ---------------- ---------------
(State or other jurisdiction (Commission File No.) (IRS Employer
of incorporation) Identification No.)
3200 Brighton Blvd., Unit 114
Denver, CO 80216
------------------------------------------------
(Address of principal executive offices, including Zip Code)
Registrant's telephone number, including area code: (303) 862-9000
1550 Larimer, Ste. 264
Denver, CO 80202
-----------------------------------------------------
(Former name or former address if changed since last report)
Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below)
[] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[] Pre-commencement communications pursuant to Rule 13e-14(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 1.01. Entry Into a Material Definitive Agreement
On June 16, 2014, the Company entered into an option agreement to purchase
a five-acre parcel of undeveloped land in Denver, Colorado. The Company plans to
develop the property as a facility called the "Denver Cannabis Center." Plans
for the Denver Cannabis Center include the construction of a 126,000 square foot
facility that would include greenhouse and indoor cultivation areas that will be
sold to licensed cannabis operators. The Company does not cultivate, process or
sell cannabis.
Additional plans for the Denver Cannabis Center include a cannabis
dispensary, a research facility, a training center, an infused product
production facility and corporate offices.
The Company paid the seller $250,000 for the option which amount will be
applied toward the purchase price of $2,250,000 at the closing. The closing must
take place on or before July 31, 2014. If the Company fails to close by that
date, through no fault of the seller, the Company will forfeit the $250,000
deposit.
The Company plans to develop comparable facilities in other states that
allow for the production and sale of cannabis. The Company's ability to develop
the Denver Cannabis Center, as well as its plans for other states, is contingent
upon its ability to obtain the capital required to fund the projects. The
Company estimates that the cost to build and develop the Denver Cannabis Center
will be approximately $8.5 million.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: July 8, 2014
AMERICANN, INC.
By:/s/ Timothy Keogh
-----------------------------------
Timothy Keogh, Chief Executive
Office
